Does Dr. OLUMIDE AJAYEOBA have financial conflicts of interest?

Dr. OLUMIDE AJAYEOBA (MD) has received a total of $1,885 in pharmaceutical and medical device industry funding between 2021 and 2025. This includes $1,885 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. OLUMIDE AJAYEOBA?

According to CMS Open Payments data, Dr. OLUMIDE AJAYEOBA received funding from BOSTON SCIENTIFIC CORPORATION ($1,513), E.R. SQUIBB & SONS, L.L.C ($120), and TAKEDA PHARMACEUTICALS U.S.A ($106).

Does Dr. OLUMIDE AJAYEOBA receive research grants or speaking fees?

Dr. OLUMIDE AJAYEOBA has received $1,885 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. OLUMIDE AJAYEOBA

MDReal-Time Hydrated

Specialty: Internal Medicine, Gastroenterology

Practice Location: DANVILLE, PA 17822

NPI Number: 1144577826

LIFETIME INDUSTRY VALUE

$1,885

2021 – 2025 Cumulative

Conflict of Interest Analysis

Dr. AJAYEOBA is a verified Internal Medicine, Gastroenterology practitioner based in DANVILLE, PA.

Between 2021 and 2025, Dr. AJAYEOBA had an overall industry promotional and research financial footprint of $1,885 as recorded in the federal CMS Open Payments database.

$1,885 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. AJAYEOBA's primary funding source is BOSTON SCIENTIFIC CORPORATION, which accounts for $1,513 (representing 80.3% of overall industry footprint).

Data coverage: 2021 – 2025 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

BOSTON SCIENTIFIC CORPORATION

Rank 1

$1,513

80.3%

E.R. SQUIBB & SONS, L.L.C

Rank 2

$120

6.3%

TAKEDA PHARMACEUTICALS U.S.A

Rank 3

$106

5.6%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2025

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.